Drug intelligence / Profile preview

Hylube

Development stage: Unknown
Lead developer: Jainson Biotech
Modality: Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration: Ophthalmic

Overview

**Hylube** is a Jainson Biotech ophthalmic fixed-dose lubricant product supplied as eye drops for dryness and irritation of the eye. It contains carboxymethylcellulose sodium, glycerin, and N-acetylcarnosine; the lubricating components moisturize and protect the ocular surface, while N-acetylcarnosine is presented by the manufacturer as an antioxidant and free-radical scavenger. ([jainsonbiotech.com](https://jainsonbiotech.com/hylube.php))

Brand names: Hylube

Beyond the preview

Go deeper on Hylube.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hylube.

Explore the full profile